#weight-loss drugs
articles
Health
Bank of America Spends $250 Million a Year on Weight-Loss Drugs for Employees, CEO Says
The disclosure from CEO Brian Moynihan underscores how GLP-1 medications are reshaping corporate healthcare budgets and ...
Companies
Anvisa Approves Five New Semaglutide Pens, Heating Up Brazil's R$5.6 Billion Weight-Loss Drug War
Brazil's health regulator cleared five additional semaglutide pens from Sandoz, Sun Pharma, Ranbaxy, and Brainfarma, sha...